Stocks and Investing Stocks and Investing
Tue, January 24, 2023

Matthew Harrison Maintained (BNTX) at Hold with Increased Target to $216 on, Jan 24th, 2023


Published on 2024-10-28 01:03:51 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "BioNTech SE" (BNTX) at Hold with Increased Target from $203 to $216 on, Jan 24th, 2023.

Matthew has made no other calls on BNTX in the last 4 months.



There are 4 other peers that have a rating on BNTX. Out of the 4 peers that are also analyzing BNTX, 3 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Emmanuel Papadakis of "Deutsche Bank" Maintained at Hold with Decreased Target to $160 on, Friday, November 11th, 2022
  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $177 on, Tuesday, November 8th, 2022
  • Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $132 on, Monday, October 24th, 2022


This is the rating of the analyst that currently disagrees with Matthew


  • Tazeen Ahmad of "B of A Securities" Upgraded from Hold to Strong Buy and Held Target at $239 on, Thursday, December 15th, 2022

Contributing Sources